Expanding the Life Sciences Business Through the Renewal of High-Performance Cosmetics
First written in FY2017-Q3. 18 of 20 entries say "Advanced", first in FY2017. Latest entry: FY2024-Q3.
The whole theme swung hardest in 2022: 2 of 17 companies on the "Worse" side.
2 other companies' latest entry also says "Other".
- FY2024-Q3Growth in new products alongside a decline in supplement salesAnnual report
「In the Consumer Healthcare segment, sales of the new cosmetics products ASTALIFT ADVANCED LOTION and ASTALIFT ADVANCED CREAM increased, but overall segment sales declined due to lower supplement sales and other factors.」
Sales of new ASTALIFT products increased, but overall Consumer Healthcare segment sales declined due to lower supplement sales and other factors. - FY2024-Q1AdvancedAnnual report
「In June 2023, the company announced the launch of the toner “ASTALIFT ADVANCED LOTION” and cream “ASTALIFT ADVANCED CREAM.” The company will continue to provide highly distinctive products that address customer needs and contribute to people's beauty and health.」
The company announced the launch of ASTALIFT ADVANCED LOTION and ASTALIFT ADVANCED CREAM, expanding its cosmetics lineup. - FY2023AdvancedAnnual report
「In March 2023, the company began selling “ASTALIFT THE SERUM BRIGHTENING,” a medicated serum for preventing dark spots from the “ASTALIFT THE SERUM” high-function serum series, which applies its proprietary liposome technology to cosmetics. The product helps prevent irritation damage to the skin caused by UV exposure and dry air, among other factors, and suppresses the production of melanin, the root cause of dark spots. It is a quasi-drug.」
The company began selling ASTALIFT THE SERUM BRIGHTENING, which applies its proprietary liposome technology, in March 2023, expanding its product lineup. - FY2023-Q3AdvancedAnnual report
「In December 2022, the company announced that it would begin selling in March 2023 “ASTALIFT THE SERUM BRIGHTENING,” a medicated serum for preventing dark spots from the “ASTALIFT THE SERUM” high-function serum series, which applies its proprietary liposome technology to cosmetics. The product helps prevent irritation damage and suppresses the formation of dark spots at its source. It is a quasi-drug.」
The company announced plans to begin selling a medicated serum for preventing dark spots, applying its proprietary liposome technology, from March 2023 in the Life Science segment. - FY2023-Q2AdvancedAnnual report
「In August 2022, the company began selling the high-function serum series “ASTALIFT THE SERUM,” which applies its proprietary liposome technology to cosmetics. The company will continue to provide highly distinctive products that address customer needs and contribute to people's beauty and health.」
The Life Science segment expanded its cosmetics lineup by launching a high-function serum series in August 2022 that applies its proprietary liposome technology. - FY2023-Q1AdvancedAnnual report
「In March 2022, the company launched the new skincare brand “cresc. by ASTALIFT” for younger consumers, designed to care for dry and sensitive skin. In June 2022, it began selling “Ayumate,” a functional food containing an active ingredient that helps reduce discomfort in the knee joints during movement, such as walking and climbing stairs.」
The Life Science segment launched the younger-consumer skincare brand cresc. by ASTALIFT and the functional food Ayumate, which targets knee-joint discomfort. - FY2022-Q2AdvancedAnnual report
「On 1 September 2021, as the first product in the series, the company launched “ASTALIFT Opme,” a highly moisturizing, long-lasting all-in-one gel with four functions: toner, serum, emulsion, and cream.」
The new ASTALIFT series “ASTALIFT Opme” expanded the product lineup with the September 2021 launch of an all-in-one gel with four functions. - FY2022-Q1AdvancedAnnual report
「In March 2021, the company launched “ASTALIFT White Jelly Aquarista,” formulated with a skin-whitening active ingredient and proprietary beauty ingredients, based on the jelly-textured pre-serum “ASTALIFT Jelly Aquarista,” a long-selling product since its launch in September 2010. The company will continue to provide highly distinctive products that address customer needs and contribute to people's beauty and health.」
The Life Science segment expanded its product lineup by launching a new product in March 2021 that added skin-whitening active ingredients and other components to an existing long-selling product. - FY2021-Q2AdvancedAnnual report
「In September 2020, the company launched the base makeup product “ASTALIFT Luminous Essence,” formulated with ingredients that retain moisture and keep skin hydrated, and the serum “ASTALIFT Sparkle Tight Serum,” which tightens skin with effervescent bubbles.」
The Life Science segment expanded its product lineup by launching an ASTALIFT base makeup product and serum in September 2020. - FY2021-Q1AdvancedAnnual report
「In the Life Science segment, store sales were affected by the spread of COVID-19, but supplements such as “Metabarrier EX” performed well through mail-order sales, driving an increase in overall sales.」
In the Life Science segment, although store sales were affected, strong supplement sales through mail order contributed to higher overall sales. - FY2020AdvancedAnnual report
「As new additions to the “ASTALIFT” brand's inner-care series, the company launched the functional foods “ASTALIFT Supplement White Shield” and “ASTALIFT Drink White Shield” in April 2020.」
The Life Science segment is expanding into ASTALIFT functional foods and drinks. - FY2020-Q2AdvancedAnnual report
「The company also launched the men's skincare series “ASTALIFT MEN” in November 2019, entering the men's cosmetics market.」
The Life Science segment entered the men's cosmetics market with the launch of the men's skincare series “ASTALIFT MEN.” - FY2019AdvancedAnnual report
「In the Life Science segment, the company began selling “ASTALIFT D-UV Clear White Solution,” which offers the highest UV protection in the ASTALIFT series, and the renewed “ASTALIFT White Essence Infilt,” with enhanced beauty benefits, in March 2019.」
For ASTALIFT, the products progressed from the previous quarter's launch announcement to the start of sales of the D-UV product and renewed product in March 2019. - FY2019-Q3AdvancedAnnual report
「In the Life Science segment, the company announced in November 2018 that it would launch in March 2019 “ASTALIFT D-UV Clear White Solution,” which offers the highest UV protection in the ASTALIFT series, and the renewed “ASTALIFT White Essence Infilt,” with enhanced beauty benefits.」
For ASTALIFT, new and renewed products were announced in November 2018, with the product rollout advancing toward their launch in March 2019. - FY2019-Q2AdvancedAnnual report
「In the Life Science segment, the company relaunched the serum “ASTALIFT Essence Destiny” in September 2018. The product is designed to give skin supple firmness and contributed to higher sales.」
The Life Science segment relaunched an ASTALIFT serum in September 2018, contributing to higher sales. - FY2018AdvancedAnnual report
「In the Life Science business, the company newly rolled out the ASTALIFT prestige series ASTALIFT IN-FOCUS and launched the comprehensive anti-aging serum ASTALIFT IN-FOCUS Cell Active Serum.」
Expanding the high-function cosmetics and functional foods business into ASTALIFT's premium series, new serums, and supplements for animals. - FY2018-Q2AdvancedAnnual report
「Sales also remained solid for two new ASTALIFT creams launched in September, a renewed emulsion, and ASTALIFT IN-FOCUS, the ASTALIFT prestige, or top-tier, series.」
In September 2017, the company introduced new and renewed ASTALIFT products and its top-tier series, with sales remaining solid. - FY2018-Q1AdvancedAnnual report
「In the Life Science business, sales performed well and revenue increased for the ASTALIFT White Bright Lotion whitening lotion, launched in March 2017, and other whitening products, as well as Metabarrier S and other foods with function claims offering two functions: suppressing sugar absorption and improving the intestinal environment.」
The company reported strong sales and higher revenue for the whitening lotion series and Metabarrier S, a food with function claims offering two functions. - FY2017AdvancedAnnual report
「In the Life Science business, the company launched renewed lotions in both the ASTALIFT and ASTALIFT WHITE series. It also launched Sutto-ne Rich Crocetin Plus, a new product in the Drink Astaxanthin series.」
In addition to renewing its high-performance lotions, the company launched a new ASTALIFT WHITE product and a food with function claims, expanding its Life Science product portfolio. - FY2017-Q3First statedAnnual report
「In the Life Science business, sales of high-performance lotions such as ASTALIFT Moist Lotion, renewed in September 2016, performed well, resulting in higher revenue.」
The company reported the renewal and increased sales of high-performance lotions as part of the expansion of its Life Science business.